Feinstein Institutes Receives $3.7M Nih Support For Bioelectronic Medicine Research
05/06/21, 1:06 PM
The Feinstein Institutes for Medical Research, the global scientific home of bioelectronic medicine, has been awarded a five-year grant totaling more than $3.7 million from the National Institutes of Health’s (NIH) National Institute of General Medical Sciences (NIGMS) to support research in the molecular basis of bioelectronic medicine. Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes, is the principal investigator leading the research.
Company Info
Additional Info
The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health system science, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn